openPR Logo
Press release

Asia IVD Market

11-30-2020 07:07 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Asia Pacific IVD Market

Asia Pacific IVD Market

According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256

The Asia-Pacific IVD market is categorized into several diagnostic techniques, among which, the immunodiagnostic and clinical chemistry segments hold the dominant share collectively accounting for half of the market share in 2015. The growing trend of diagnostic tools such as, clinical chemistry and molecular diagnostic would largely drive the market growth during the forecast period. However, blood testing is projected to be the fastest growing segment, owing to its frequent application and inherent convenience of using blood samples.

Increasing government initiatives, growing R&D activities for advanced diagnostics techniques, improving healthcare infrastructure, and rising per capita healthcare expenditure largely drive the Asia Pacific IVD market growth. On the other hand, lack of harmonization in regulatory guidelines coupled with inadequate reimbursement policies and technological barriers are hindering the market growth. However, the wide scope of application in various biological and medical diagnostics industries to create lucrative opportunities in the near future.

Inquiry for Buying Report @ https://www.alliedmarketresearch.com/purchase-enquiry/1256

Key findings of the study:

Infectious diseases segment is expected to maintain its foothold in the Asia-Pacific IVD market.

Cancer is projected to be the fastest growing application segment during the forecast period.

In 2015, infectious diseases and immune system disorders collectively accounted for about half of the Asia-Pacific IVD indication market.

Asia-Pacific IVD Instruments market is projected to witness the highest CAGR of 7.1% during the forecast period.

India is forecasted to be the fastest growing market, growing at a CAGR of 7.1% from 2016 to 2022.

In 2015, China and Japan collectively accounted for around two-third of the Asia Pacific IVD market revenue.

The leading companies profiled in this report are, F. Hoffmann-La Roche AGR, Abbott Laboratories, Danaher Corporation, Johnson & Johnson, Sysmex Corporation, Becton Dickinson and Company, bioMrieux, Thermo Fisher Scientific, Inc., Ortho-Clinical Diagnostics, Siemens AG, and Alere Inc, Vela Diagnostics, Affymetrix, Alere Inc., Bio-Rad Laboratories, Arkray Inc., Sysmex Corporation, and Trans Asia BioMedicals Ltd. They have adopted different strategies such as mergers & acquisitions, partnerships, collaborations, new product launches, and others to gain a strong position in the global industry.

Read More @ https://www.alliedmarketresearch.com/press-release/asia-pacific-IVD-market.html

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia IVD Market here

News-ID: 2199015 • Views: 361

More Releases from Allied Market Research

Instant Tea Premix Consumption Market Key Players, Industry Demand, Overview And …
Rise in concerns related to obesity, increase in health awareness, surge in the disposable income, and growing demand for ready-mixed drinks fuel the growth of the global instant tea premix consumption market. On the other hand, increase in trend of coffee consumption and fluctuating prices of raw materials caused by unpredictable climatic conditions impede the growth to some extent. Nevertheless, rise in demand for herbal tea and introduction of new
Sartans Market is Dominated by North America and Europe
According to a new report published by Allied Market Research, titled,” Sartans Market by Product Type (Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan), Application (Hypertension, Cardiovascular Diseases, Kidney Diseases and Others) and End User (Hospitals, Diagnostic Laboratories, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". The Global market size of Sartans is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of
Licorice Extract Market Analysis and In-depth study on market Size Trends, Emerg …
Benefits of licorice extracts for treatment of Covid-19 and rise in demand from the cosmetic industry fuel the growth of the global licorice extract market. On the other hand, availability of a variety of substitutes for licorice in the food & beverage industry impedes the market growth to some extent. However, demand from the animal feed industry and increase in popularity of natural & clean label products would pave the
Marine Derived Pharmaceuticals Market Development Trends, Key Drivers and Compet …
According to a new report published by Allied Market Research, titled,” Marine Derived Pharmaceuticals Market by Type (Phenol, Steroid, Ether, Peptide, Mollusk, Sponge, Tunicate and Others), Source (Algae, Invertebrates, and Microorganisms), Mode of Delivery (Anti-microbial, Anti-tumor, Anti-cardiovascular, Anti-viral, Anti-inflammatory, and Others) and End User (Hospitals, Retail Pharmacy. Online Pharmacy and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". The Global market size of Marine Derived Pharmaceuticals is $XX million in 2020

All 5 Releases


More Releases for Asia

RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
MES: Expansion in Asia
Berlin, November 24, 2014: Model Engineering Solutions (MES), the Berlin-based specialist for model-based software development, has significantly expanded its business in Asia. In recent years, MES has built up a network of local partners in Japan, Korea, China, and India in order to benefit from the growing market and increasing interest in model-based development and ISO 26262 in Asia. Asia: Driving force in the automotive industry The automotive industry continues
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
UDT Asia 2011
Clarion Events hosts the Undersea Defence Technology (UDT) Asia 2011 conference and exhibition to bring senior naval and industry personnel together to cover underwater developments in the region Singapore, May 30 – Clarion Events is hosting UDT Asia on 30 November – 1 December 2011. The event brings together the undersea defence community in Asia, featuring top regional naval speakers, who will be addressing the latest underwater requirements for Asian navies. According
eltherm goes Asia
Finally all preparations are finished and the new subsidiary of eltherm GmbH, eltherm Asia Pacific Pte Ltd has commenced operations in Singapore on 1st April 2010. To celebrate the starting shot, an opening celebration was held in the afternoon of 28th July in the office premises followed by a get together dinner and drinks in the evening at a pub. A total of 62 guests attended the event with the